GoTo Telemed Launches First-of-its-Kind Congenital Heart Disease Management Program

KALISPELL, Mont. - June 4, 2026 - PRLog -- GoTo Telemed, the nation's leading integrated telehealth ecosystem serving over 10 million patients nationwide, today announced the launch of its dedicated Congenital Heart Disease (CHD) Management Program, a comprehensive, first-of-its-kind virtual care initiative designed to provide lifelong, guideline‑aligned support for the nearly 2.4 million Americans living with congenital heart defects. The program integrates continuous remote monitoring using next‑generation wearables and AI, seamless pediatric‑to‑adult care transition, reproductive and genetic counseling, psychosocial support, and ACHD specialist consultation through a secure, unified telehealth platform.

Today, 95% of children born with CHD survive to adulthood, creating a rapidly growing population of adults with congenital heart disease (ACHD) that now outnumbers pediatric CHD patients and is expanding by 5% annually. The median age of the ACHD population has increased from 40 to 54 years over the past decade, yet less than half of eligible adults receive specialized ACHD care, leaving millions at risk for preventable complications, hospitalizations, and premature death. Recent data from a 2025 telemedicine study of moderate‑to‑severe ACHD patients demonstrated that a device‑based remote monitoring program significantly reduced hospital admission days and related costs while maintaining stable clinical status and achieving high patient satisfaction.

"Congenital heart disease is not cured—it is managed for life. Yet the vast majority of adults with CHD are lost to follow‑up after aging out of pediatric cardiology, and those who remain in care face fragmented systems, geographic barriers, and a shortage of specialized ACHD centers," said a GoTo Telemed spokesperson. "Our CHD Management Program changes this paradigm. We are integrating AI‑enabled wearables that monitor oxygen saturation, heart rhythm, and activity in real time; a digital transition platform that guides young people from pediatric to adult care without interruption; and direct access to ACHD cardiologists who interpret data, adjust medications, and coordinate with local providers—all through a single, unified virtual platform."

AI-Enabled Remote Monitoring & Wearable Technology

A cornerstone of the program is continuous, at‑home physiologic monitoring using next‑generation wearable biosensors and AI‑enhanced data interpretation. A 2025 American Heart Association Science Advisory endorsed wearables to facilitate proactive management and early detection of complications in CHD patients, particularly for high‑risk infants with shunt‑dependent single‑ventricle physiology. Wearables allow patients to access their personal data, monitor their health, and may enhance existing home monitoring.

AI offers significant advancements across the CHD care spectrum, from prenatal screening to postnatal management and long‑term monitoring. AI‑enabled remote monitoring and wearable technologies facilitate proactive management and early detection of complications, which is crucial throughout the patient's life.

Media Contact:
GoTo Telemed Media Relations
info@gototelemed.com
(660) 628-1660
https://gototelemed.com/